 The Enterprise Immune System further employs an autonomous response technology, Antigena, which allows networks to take instant and autonomous action against in-progress cyber-attacks.Antigena takes targeted action, for example slowing down or stopping a compromised connection or device, in order to neutralize threats without impacting normal business operations.One end user, Michael Sherwood at City of Las Vegas commented, "Darktrace Antigena is the only automated response technology that is capable of fighting the most important battles for us.